# PALBOCICLIB
> **ANDA212980** · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA LIMITED · Approved 2026-02-25
## Drug
- **FDA Application Number:** ANDA212980
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PALBOCICLIB
- **Generic name:** Palbociclib
- **Active ingredients:** PALBOCICLIB
- **Dosage form:** CAPSULE
- **Route:** —
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** CIPLA LIMITED
- **First approval:** 2026-02-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212980)
---
*AI Analytics · CC0 1.0*